Apart from the HLA genes which have been extensively studied, other regulatory components of the APM such as those involved in transcriptional regulation (e.g., CIITA) or transport of peptides (e.g., TAP1 and TAP2) are interesting candidates for exploration of their effect on CRC. The gene discussed is TAP2; the disease is colorectal carcinoma.